loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 2472945 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BUPROPION HYDROCHLORIDE (1)

02 NALTREXONE HYDROCHLORIDE (1)

filter

01 BAUSCH HEALTH, CANADA INC. (2)

filter

01 TABLET (EXTENDED-RELEASE) (2)

filter

01 8MG (1)

02 90MG (1)

filter

01 Canada (2)

URL Supplier Web Content
TABLET (EXTENDED-RELEA...
8MG
CONTRAVE
Canada
2472945
70/120
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET (EXTENDED-RELEA...
90MG
CONTRAVE
Canada
2472945
70/120
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2472945

Looking for CTD TGA MCC DOSSIER APPLICATION 2472945 2

19

Bausch Health, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is NALTREXONE HYDROCHLORIDE, with a corresponding application number 2472945 and regulatory information .

proudly manufactured in the

Bausch Health's CONTRAVE TABLET (EXTENDED-RELEASE), medication with 8MG of NALTREXONE HYDROCHLORIDE.

18

Bausch Health, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BUPROPION HYDROCHLORIDE, with a corresponding application number 2472945 and regulatory information .

proudly manufactured in the

Bausch Health's CONTRAVE TABLET (EXTENDED-RELEASE), medication with 90MG of BUPROPION HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY